Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Galapagos NV ADR
GLPGCurrent price
25.82 USD
+0.26 USD (+1.02%)
Last closed
26.10 USD
Company
www.glpg.com
ISIN
US36315X1019
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 773 291 008 USD
Yield for 12 month
-20.99 %
1Y
3Y
5Y
10Y
15Y
GLPG
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Address: Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
29.99 USDP/E ratio
–Dividend Yield
–Current Year
+251 827 325 USD
Last Year
+530 790 871 USD
Current Quarter
+62 870 691 USD
Last Quarter
+81 804 697 USD
Current Year
+214 021 291 USD
Last Year
+518 102 019 USD
Current Quarter
+62 850 732 USD
Last Quarter
+64 411 759 USD
Key Figures GLPG
1 year
3 years
5 years
10 years
EBITDA
-136 034 752 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-2.38 %
PEG Ratio
–
Return On Equity TTM
-2.21 %
Wall Street Target Price
29.99 USD
Revenue TTM
260 094 000 USD
Book Value
43.41 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-50.10 %
Dividend Yield
–
Gross Profit TTM
4 818 000 USD
Earnings per share
-0.97 USD
Diluted Eps TTM
-0.97 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
74.80 %
Profit Margin
79.33 %
Dividend Analytics GLPG
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History GLPG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation GLPG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
166.67
Enterprise Value Revenue
1.18
Price Sales TTM
6.82
Enterprise Value EBITDA
-31.50
Price Book MRQ
0.59
Financials GLPG
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GLPG
For 52 weeks
24.16 USD
42.46 USD
50 Day MA
28.03 USD
Shares Short Prior Month
1 504 953
200 Day MA
28.47 USD
Short Ratio
5.39
Shares Short
1 726 578
Short Percent
3.51 %
BeatStart